Company: MLTX
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001821586-25-000018
Chunk: 0

Company: MoonLake Immunotherapeutics
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
s

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)June 30, 2025 (Unaudited)December 31, 2024AssetsCurrent assetsCash and cash equivalents$306,681$180,426Short-term marketable debt securities118,402267,601Other receivables3,4092,844Prepaid expenses26,98923,418Total current assets455,481474,289Non-current assetsOperating lease right-of-use assets2,2512,922Property and equipment, net667722Other non-current assets1,697—Total non-current assets4,6153,644Total assets$460,096 $477,933Liabilities and EquityCurrent liabilitiesTrade and other payables$17,079 $8,992 Accrued expenses and other current liabilities8,73212,099Short-term portion of operating lease liabilities1,5501,372Total current liabilities27,36122,463Non-current liabilitiesLong-term debt73,381—Long-term portion of operating lease liabilities8361,458Pension liability574621Total non-current liabilities74,7912,079Total liabilities102,15224,542Commitments and contingencies (Note 16)Shareholders' equityClass A Ordinary Shares: $0.0001 par value per share; 500,000,000 shares authorized; 63,474,253 shares issued and outstanding as of June 30, 2025; 63,077,431 shares issued and outstanding as of December 31, 202466Class C Ordinary Shares: $0.0001 par value per share; 100,000,000 shares authorized; 729,320 shares issued and outstanding as of June 30, 2025; 841,269 shares issued and outstanding as of December 31, 2024——Additional paid-in capital683,962677,415Accumulated deficit(330,757)(235,593)Accumulated other comprehensive income5204,997Total shareholders’ equity 353,731446,825Noncontrolling interests4,2136,566Total equity357,944453,391Total liabilities and equity$460,096$477,933    

The accompanying Notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.

2

MOONLAKE IMMUNOTHERAPEUTICSCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS